Latest Profitability News

Australian Vintage Ltd reported a modest 1% revenue decline in FY25 but significantly narrowed its net loss, setting the stage for a transformational FY26 driven by new CEO leadership and innovative product launches.

Cadence Opportunities Fund Limited reported a solid 7.9% gain for the 2025 financial year, driven by strong gold mining stocks and strategic portfolio moves. The fund also declared a fully franked final dividend of 7.0 cents per share, reflecting confidence despite ongoing economic uncertainties.

Nex Metals Explorations has partnered with the Wangkatja Tjungula Aboriginal Corporation to reprocess historic gold tailings at Kookynie, sharing profits and embedding cultural stewardship in rehabilitation efforts.

Cadence Opportunities Fund Limited reported a 36% drop in profit after tax for FY2025 but maintained its fully franked final dividend at 7.0 cents per share, signaling confidence despite softer earnings.

Cadence Capital Limited reported a $6.3 million profit and a 3.4% fund gain for FY25, driven by strong gold sector performance. The company announced a 3.0 cent final dividend with a dividend reinvestment plan and on-market buy-back.

Cadence Capital Limited reported a sharp decline in profit for FY2025, down 71% from the prior year, while declaring a steady 3.0 cent final dividend and continuing its share buy-back program.

Globe International Limited reported a decline in revenue and profit for FY25, reflecting a strategic shift away from non-core brands. Despite this, the company maintains strong profitability in Australia and a solid cash position, while declaring a fully franked dividend of 20 cents per share.

Aerometrex has confirmed Robert Veitch as its new CEO and Managing Director, following a strategic overhaul that delivered $2 million in annual cost savings and boosted its MetroMap revenue stream.

Desane Group Holdings anticipates a strong leap in earnings before interest and tax for FY25, nearly doubling last year’s figure. The final audited results are expected by the end of August.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Objective Corporation Limited reported a robust FY2025 with 15% growth in annualised recurring revenue, driven by strong SaaS adoption and strategic AI integration across its GovTech portfolio.